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Tonsillectomy (TE) or adenotonsillectomy (ATE) may have a beneficial effect on the 
clinical course in children with the periodic fever, aphthous stomatitis, pharyngitis and 
cervical adenitis (PFAPA) syndrome. However, an immunological reason for this effect 
remains unknown. This literature review summarizes the current knowledge regarding the 
immunological role of the tonsils in the PFAPA syndrome.  
 
Methods 
We searched PubMed, Medline, EMBASE and Cochrane for papers written in English dated 
from 1 January 1987 to 30 April 2019. The search included all studies reporting histological, 
immunological or microbiological workup of tonsil specimens from children aged 0 to 18 
years with PFAPA. 
Results 
Thirteen articles reported histological, immunological or microbiological workup of tonsil 
specimens in children with PFAPA. The histology of tonsil specimens from children with 
PFAPA displayed chronic tonsillar inflammation with lymphoid hyperplasia. No uniform 
immunological pattern was identified, but some studies found fewer B-lymphocytes and 
smaller germinal centers in PFAPA compared to controls. A difference in tonsillar microbiota 





A uniform immunological or microbiological pattern explaining the clinical effect of TE in 
children with PFAPA has not been revealed. Future targeted immunological studies of tonsils 
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The periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) 
syndrome is the most common paediatric periodic fever syndrome [1, 2], with a cumulative 
incidence of 2.2 per 10,000 children up to the age of 5 years in a Nordic population [2]. The 
hallmarks of the disease are short, regularly occurring episodes of high fever accompanied by 
at least one of the following major symptoms: pharyngitis, cervical adenitis and aphthous 
stomatitis [3-5]. Episodes of PFAPA often start during the first few years of life and often 
spontaneously resolve during late childhood [2, 6]. The criteria for establishing a PFAPA 
diagnosis was suggested by Thomas et al. in 1999 and have been widely used in international 
studies, however, there is no established international consensus regarding the definition of 
PFAPA today [7, 8]. 
A dysregulated interleukin (IL)-1 response may play a part in the etiology of the 
disease [9, 10], and PFAPA is currently regarded as an autoinflammatory disease [11]. Unlike 
the classical hereditary periodic fever syndromes including familial Mediterranean fever, 
mevalonate kinase deficiency and TNF-receptor associated periodic syndrome, PFAPA has 
not been defined genetically. Several candidate genes have been proposed as contributing 
factors to the etiology of PFAPA, and in addition some studies show familiar clustering of the 
disease. A polygenic basis for the disease is likely, but further studies are needed to elucidate 
this. As recently reviewed, an environmental trigger causing immunological reactions with 
febrile flares in a genetic predisposed host seems the best founded model for the disease today 
[12]. 
Since PFAPA was first described as a clinical entity by Marshall et al. in 1987 [13], a 
beneficial effect of tonsillectomy (TE) or adenotonsillectomy (ATE) has been reported in 
several case series [14] and two randomized controlled trials of children with PFAPA [15, 
16]. Both a Cochrane review and a recent review of all case series conclude that TE or ATE 
 
 
may have a curative effect on children with PFAPA, but the evidence is of moderate quality 
[14, 17]. 
The palatine tonsils (referred to as the tonsils in this paper), together with the 
adenoids and the lingual tonsils constitute a large part of what is called Waldeyer’s ring. 
This lymphoid tissue is strategically located in the aerodigestive tract exposed to 
airborne and alimentary antigens [18]. The reason why TE or ATE may have a beneficial 
effect in children with PFAPA is not known. Some studies have explored different 
immunological aspects of the tonsils and the tonsillar microbiota in children with 
PFAPA. The aim of this article was to summarize the results of all studies reporting 
histological, immunological and microbiological findings in tonsils from these children.  
 
2. Methods 
A systematic search of the PubMed, Medline, EMBASE and Cochrane databases was 
performed up to April 30th 2019 using the keywords “Marshall Syndrome”, “PFAPA” and 
“Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis”. Papers in English 
language published between 1 January 1987 and 30 April 2019 were checked for relevance. 
The references in the relevant papers were also reviewed to identify any articles not found in 
the systematic search. Papers were included if they reported histological, immunological or 
microbiological studies of tonsil specimens from children aged 0 to 18 years diagnosed with 
PFAPA. The diagnostic criteria for the diagnosis in each study were noted; if they were 
according to Marshall [13], Thomas [7] or adapted criteria not clearly based on either of 
the two. The diagnostic criteria according to Marshall and Thomas are presented in 





The search retrieved 13 articles reporting microbiological, histological or 
immunological workup of tonsil specimens in children with PFAPA (Figure 1). Two articles 
included only one and two patients with PFAPA, and were therefore not included in the 
further presentation [19, 20]. Data from the remaining 11 articles including four or 
more children are summarized in Table 2. 
 
3.1 Histological and immunological evaluation of tonsils in PFAPA 
 The histology of tonsils from children with PFAPA has been evaluated in eight studies 
[21-28]. All studies reported similar findings, with tonsil specimens showing signs of chronic 
tonsillar inflammation with lymphoid hyperplasia. Four of these studies compared the 
histologic findings with a control group [24-26, 28]. With the exception of one study 
presenting differences in measurements of germinal centers and epithelium width (presented 
in detail below) [28], the studies showed no difference between the children with PFAPA and 
the controls.  
In six studies, the tonsils were characterized further by immunhistochemical staining 
for various cell types and protein expression and/or gene expression studies [23-25, 28-30].   
Peridis et al. reported preservation of normal tonsillar architecture after 
immunohistochemically staining of T and B lymphocytes, using markers for cluster of 
differentiation (CD) 3 and CD20, respectively [23].  
Dytrych et al. examined manually dissociated tonsil tissue from children with PFAPA 
compared to controls with obstructive sleep apnoea syndrome. They found a lower percentage 
of B lymphocytes (CD19+) and an increased proportion of cytotoxic T cells (CD8+). 
Additionally, some subsets of lymphocytes (translational B cells, naïve stages of CD4+ and 
CD8+ cells with a low expression of the PD-1 molecule and a high number of T-cell receptor 
excision circles) were found to be increased in tonsil tissue from children with PFAPA. 
 
 
Polymerase chain reaction (PCR) studies for rearrangement of immunoglobulin and T cell 
receptors did not show clonal or oligoclonal expansion. The expression of the chemokine 
CXCL10, CXCL9 and CCL19 genes were significantly higher in the tonsils of children with 
PFAPA syndrome. The authors interpreted that their results may indicate that the differences 
in the T-cell compartment observed in tonsils and not in blood could partly explain the effect 
of tonsillectomy seen in children with PFAPA, and further that the altered gene expression of 
T cell chemoattractants in tonsils may be a precipitating cause of PFAPA [24]. 
 Førsvoll et al. compared tonsils from children with PFAPA and controls with tonsillar 
hypertrophy. They found a decreased number of cytotoxic T cells (CD8+) in tonsillar 
germinal centers in children with PFAPA compared to controls, but they found no differences 
for the other cell types studied (CD3+, CD4+, CD15+, CD20+, CD45+, CD57+ and 
CD163+). The authors interpreted that their results may indicate that the regulation of CD8+ 
T lymphocytes homing to lymphoid follicles in tonsils is linked to the etiology of PFAPA 
[25].  
Manthiram et al. measured the size of germinal centers, mantel width, interfollicular 
distance ant the width of the squamous epithelium and performed immunohistochemical 
staining in cases and controls with obstructive sleep apnea. The two groups were clearly 
defined as a polysomnography was performed in all participating children. The average 
germinal center area was smaller and the average squamous epithelium width was wider in 
children with PFAPA compared to children with obstructive sleep apnea.  Mantle width and 
interfollicular distance were not significantly different. In children with PFAPA the size of 
the tonsil germinal centers were larger with longer time from the last febrile episode. Positive 
staining for the CD markers (CD1a, CD3, CD4, CD8, CD11c, CD14, CD20 CD56, CD68), 
Foxp3, TUBB2A and IL-6 and IL-1RA expression were not significantly different in children 
with PFAPA and controls in any of the major histologic compartments (crypt, germinal 
 
 
center, and surface squamous epithelium). The authors interpreted that their results may 
indicate that tonsils from children with PFAPA change histologically over time and that 
germinal centers may shrink around the time of PFAPA flares [28]. 
Gazi et al. compared tonsillar expression levels of antimicrobial peptides, namely 
human beta-defensin 1 and 2, cathelicidin, ribonuclease-7, and liver expressed antimicrobial 
peptide-1, between children with PFAPA and controls with group A beta-hemolytic 
streptococcal recurrent tonsillitis. They found no difference in the overall expression of 
antimicrobial peptides between cases and controls. However, they found a different pattern of 
localization of human beta-defensin 1 when comparing the two groups. The authors 
interpreted that their results may indicate that PFAPA patients have altered antimicrobial 
peptide expression pattern compared to normal tonsils [30].  
Valenzuela et al. compared tonsils from children with PFAPA with tonsils from 
controls operated on due to hypertrophic tonsils. They reported lower gene expression for IL-
4 in tonsils from children with PFAPA compared to controls, but otherwise they observed no 
differences in gene expression for IL-1β, IL-17, tumor necrosis factor-α, transforming growth 
factor-β and interferon-γ. The authors interpreted that their results may indicate that an 





3.2 Microbiological evaluation of tonsils 
 In two studies published by a group in Finland where the data apparently is collected 
from the same group of patients, the tonsillar microbiota in children with PFAPA was 
explored using bacterial and yeast cultures, virus PCR, electron microscopy of biofilm and 
bacterial DNA extraction [26, 31]. The culture and PCR tests showed that Candida albicans 
was more common in the PFAPA patients than in the controls, and Staphylococcus aureus, 
Varicella zoster and Herpes simplex viruses occurred less often in the children with PFAPA 
than in the controls. In addition, biofilm was more frequently present in the tonsils from the 
children with PFAPA. When using sequencing technology, the study group also found some 
significant differences in the microbiota of the tonsils from the children with PFAPA 
compared to the controls. Cyanobacteria were more common in children with PFAPA than in 
the controls. Streptococci, although present in all samples of both groups, showed lower 
relative abundance in children with PFAPA than in the controls. The authors interpreted that 
their results may indicate that the tonsillar microbiota play a role in triggering the 
inflammatory process causing PFAPA, and that removal of this triggering microbial factor in 
part explain why TE is effective in children with PFAPA [26, 31]. 
 Furthermore, Dytrych et al. found DNA from the Epstein-Barr virus, Human 
Herpervirus-6 or adenovirus in 7 of 10 tonsil specimens from children with PFAPA, but also 




Several studies have indicated that a dysregulated immune system may play a part in 
the aetiology of PFAPA [9, 10, 32-35]. In 2011, Stojanov et al. proposed a model for PFAPA 
where a microbial trigger initiates a cascade leading to the febrile attacks. They suggested that 
an immunologically immature host or a host with an inherited or acquired immune 
 
 
abnormality plays a permissive role [9]. The observation that removal of the tonsils, a minor 
part of the adaptive immune system, may be curative for a disease that is possibly caused by a 
generally dysregulated immune system is puzzling. Although both tonsillectomy and 
adenoidectomy were done in some cases, immunological workup was described only on 
tonsil specimens. The histological and microbiological studies of tonsils in children with 
PFAPA published so far reveals no clear answer to this puzzle. 
 
4.1 Histological and immunological evaluation 
The histology of tonsil specimens from children with PFAPA reveals chronic tonsillar 
inflammation with lymphoid hyperplasia. Together with the evident pharyngitis present in the 
majority of patients during febrile attacks, this clearly shows that the tonsils are an 
immunological active organ in PFAPA. However, the signs of inflammation were similar in 
controls, and may therefore be considered as inflammatory changes not specific for PFAPA. 
The existing studies on the immunological aspects of tonsils in PFAPA differ in 
design and focus, and they are not easily comparable. There is no common thread in their 
results, and there is not a clear answer regarding how the immunology of the tonsils 
contributes to the pathogenesis of PFAPA or why TE may be beneficial. However, the results 
point out some apparent interesting aspects of tonsillar immunology, and may indicate areas 
that should be elucidated in future studies. The immaturity of polyclonal lymphocytes with 
increased T-cell receptor excision circles content and higher expression of chemoattractants 
may be interpreted as the influx of thymal recruits, reactive to the febrile episode [24]. 
Dytriych et al. (2015) and Manthiram et al. (2018) found fewer B-lymphocytes and smaller 
germinal centers in tonsils indicating some regulatory disturbances, possibly by T cells.  
Indeed, Førsvoll et al. (2013) demonstrated significantly fewer follicular CD8+ T cells in 
tonsils of PFAPA children. Future studies using quantitative multiplex immunohistochemistry 
 
 
could reveal cell subtypes in more clarifying detail, and can even be performed in archival 
material [36].  
There is a paucity of publications focusing on the cyclic, infradian, nature of PFAPA. 
Clock-related genes and their relation to immunity are well described (reviewed in [37]), but 
most publications on clock genes relate to circadian and not the infradian rhythms as seen in 
PFAPA. Yet, there are rhythmic fluctuations of inflammatory pathways and clock genes are 
associated with increased cellular oxygen concentration [38]. Probing into clock genes in 
tonsillar tissues may therefore be of interest.  Another possible approach may be to probe 
expressed genes of the inflammasomes in PFAPA tonsils [39]. 
TE or ATE in children with PFAPA are performed during the afebrile interval, and 
this may limit the information provided when studying the immunology of the tonsils, as 
important immunological aspects of PFAPA may be absent outside the febrile intervals. This 
may be illustrated by Manthiram et al.’s finding of altered tonsil germinal centers size with 
longer time from the last febrile episode [28]. Tonsil specimens are not available from healthy 
controls, and results found when comparing tonsils from children with PFAPA and from 
children with other diseases can be difficult to interpret.  
 
4.2 Microbiological evaluation of tonsils  
 Some differences in the presence of Candida albicans and some common viruses and 
bacteria were found in the Finnish studies comparing biofilm samples from children with 
PFAPA and a control group [26, 31]. This could indicate that children with PFAPA have an 
altered tonsillar microbiological milieu. However, the varying degrees of biofilm, bacteria and 
fungi present in the upper airways may also have been caused by differences in the use of 
antibiotics prior to surgery in children with and without PFAPA. 
 
 
The lack of a clear clinical definition for PFAPA and inclusion criteria for patients 
could also bias studies regarding the possible role of microbiological agents in PFAPA. Padeh 
et al. diagnosed PFAPA only in children with no effect of antibiotic treatment, either as a 
treatment during febrile episodes or as a prophylaxis, or when they had negative throat 
cultures during the attacks [3]. Thomas et al. and Tasher et al. had a less systematic approach, 
but their findings are comparable, with no effect from antibiotics in 92% and 98% of children, 
respectively [5, 7]. 
 
4.3 Limitation of the studies 
 PFAPA is diagnosed using clinical criteria, and although the criteria presented by 
Thomas et al. in 1999 are the most commonly used in studies, there is no international 
consensus. This may cause heterogeneity in study populations and thus in results of 
immunological studies. Recently, the Eurofever network has proposed classification criteria 
for PFAPA intended for clinical, epidemiological and translational studies [40]. These criteria 
are not meant to be diagnostic criteria for clinical practice, but as inclusion criteria in studies. 
The authors argue that this will facilitate the accurate identification of PFAPA and 
differentiating it from other autoinflammatory diseases.  
The studies performed on children with PFAPA are performed on study populations 
ranging from 4 to 31 cases with 0 to 24 controls. There is a risk of finding a false positive or a 
false negative results when a high number of comparisons are made on relatively few patients 
and controls [41]. This may be the cause of the lack of reproducibility for some of the results 
seen in the different studies of tonsils in PFAPA. Collecting children in order to reach a 
sufficient sample size for a tonsillectomy-PFAPA-study is time consuming, and to help this 






Only a few studies have explored immunological and microbiological aspects of tonsils in 
children with PFAPA, suggesting a role for the tonsils in the pathophysiology of PFAPA, but 
no common immunological explanation for the possible effect of TE has been found. More 
and thorough immunological studies could possibly substantiate the possible effect of TE or 
ATE in PFAPA and illuminate the understanding of the immunology in this disease.  
 
List of abbreviations: 
ATE: Adenotonsillectomy 
CD: Cluster of differentiation 
IL: Interleukin  
PCR: Polymerase chain reaction 
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